Cargando…

Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia

Activation of hepatic stellate cells reportedly contributes to progression of hepatocellular carcinoma (HCC). Herein, we use quantitative proteomics and ingenuity pathway analysis to show that transglutaminase 2 (TGM2) is upregulated in the course of activated hepatic stellate cells promoting epithe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hui, Xie, Liqi, Zhang, Lan, Yin, Xin, Jiang, Hucong, Xie, Xiaoying, Chen, Rongxin, Lu, Haojie, Ren, Zhenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202353/ https://www.ncbi.nlm.nih.gov/pubmed/30393774 http://dx.doi.org/10.1038/s42003-018-0177-5

Ejemplares similares

IDO and intra‐tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2019)

GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
por: Niu, Gengming, et al.
Publicado: (2021)

Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
por: Kluckova, Katarina, et al.
Publicado: (2018)

Role of pseudohypoxia in the pathogenesis of type 2 diabetes
por: Song, Jing, et al.
Publicado: (2019)

Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype
por: Celada, Lucía, et al.
Publicado: (2022)

Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells
por: NAGAHARA, TERUYA, et al.
Publicado: (2015)

Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells
por: Pan, Qin, et al.
Publicado: (2015)

Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
por: Dong, Yinying, et al.
Publicado: (2019)

Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
por: Zou, Jixue, et al.
Publicado: (2019)

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
por: Fisher, Matthew L., et al.
Publicado: (2015)

BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells
por: Jiang, Zhong-Yang, et al.
Publicado: (2023)

Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells
por: Zou, Xiaomeng, et al.
Publicado: (2022)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
por: Ma, Hui, et al.
Publicado: (2021)

LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
por: Zhan, Yating, et al.
Publicado: (2023)

Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
por: Liu, Jingmei, et al.
Publicado: (2023)

Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
por: Kumar, Anupam, et al.
Publicado: (2010)

Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition
por: Ayinde, Oluseyi, et al.
Publicado: (2019)

T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
por: Montironi, Chiara, et al.
Publicado: (2023)

Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells
por: Kumar, Anupam, et al.
Publicado: (2012)

Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6/IL6R/STAT3 axis in Hepatocellular Carcinoma
por: Jia, Changchang, et al.
Publicado: (2020)

Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study
por: Yuan, Jia, et al.
Publicado: (2019)

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
por: Zecchini, Vincent, et al.
Publicado: (2014)

Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
por: Hayashi, Yoshihiro, et al.
Publicado: (2019)

Exploiting the Role of Hypoxia-Inducible Factor 1 and Pseudohypoxia in the Myelodysplastic Syndrome Pathophysiology
por: Stergiou, Ioanna E., et al.
Publicado: (2021)

In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
por: Masola, Valentina, et al.
Publicado: (2019)

Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells
por: Ayinde, Oluseyi, et al.
Publicado: (2017)

Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014)

MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-β1/Smad signaling pathway
por: Cheng, Bianqiao, et al.
Publicado: (2019)

Prolonged Pseudohypoxia Targets Ambra1 mRNA to P-Bodies for Translational Repression
por: Pourpirali, Somayeh, et al.
Publicado: (2015)

P593: T-CELL DYSFUNCTION BY PSEUDOHYPOXIA AND AUTOCRINE PURINERGIC SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Montironi, Chiara, et al.
Publicado: (2023)

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
por: Dong, Qiongzhu, et al.
Publicado: (2016)

The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis
por: Yan, Mengchao, et al.
Publicado: (2023)

miR-375 affects the hedgehog signaling pathway by downregulating RAC1 to inhibit hepatic stellate cell viability and epithelial-mesenchymal transition
por: Liang, Zhiwei, et al.
Publicado: (2021)

Succinate Supplement Elicited “Pseudohypoxia” Condition to Promote Proliferation, Migration, and Osteogenesis of Periodontal Ligament Cells
por: Mao, Huimin, et al.
Publicado: (2020)

Myocardial Adaptation in Pseudohypoxia: Signaling and Regulation of mPTP via Mitochondrial Connexin 43 and Cardiolipin
por: Ferko, Miroslav, et al.
Publicado: (2019)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
por: Gurzu, Simona, et al.
Publicado: (2019)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells
por: Wang, Zheng, et al.
Publicado: (2013)

DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer
por: Chen, Xianliang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sa1s52v8go3l3vsvmpmcj5qu6v